Physician profile
Jeffrey Augustine
NPI 1538343561
$22,849.41
in general payments reported to CMS, 2019-2025
17 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,324 · 2020: $4,566 · 2021: $235 · 2022: $1,142 · 2023: $3,705 · 2024: $4,572 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,550 · Consulting Fee: $1,800 · Travel and Lodging: $1,294 · Food and Beverage: $933 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,550.00 |
| Consulting Fee | $1,800.00 |
| Travel and Lodging | $1,294.28 |
| Food and Beverage | $933.05 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $18,000.19 | 2019-2024 | Visumax |
| Carl Zeiss Meditec USA, INC. | $3,764.44 | 2022-2025 | Visumax |
| Eyevance Pharmaceuticals LLC | $282.97 | 2019 | |
| Ocular Therapeutix, INC. | $146.48 | 2020 | |
| Staar Surgical Company | $105.46 | 2019 | |
| Shire North American Group INC | $100.45 | 2019 | |
| Abbvie INC. | $89.74 | 2022-2023 | Vuity |
| Dompe US, INC. | $79.47 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $60.73 | 2024-2025 | Xiidra, Infuse, Miebo |
| Novartis Pharmaceuticals Corporation | $51.98 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $38.53 | 2025 | Xdemvy |
| Sight Sciences, INC. | $30.49 | 2024 | Omni Surgical System |
| New World Medical,INC. | $27.99 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.70 | 2019 | |
| Alcon Vision LLC | $19.68 | 2024 | Precision 1 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $15.92 | 2019 | |
| Allergan, INC. | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Augustine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.